, Tracking Stock Market Picks
Enter Symbol:
Ds Healthcare Group Inc. (DSKX) [hlAlert]

up 41.86 %

Ds Healthcare Group Inc. (DSKX) rated Buy with price target $5.50 by Aegis Capital

Posted on: Wednesday,  Oct 30, 2013  8:25 AM ET by Aegis Capital

Aegis Capital rated Buy Ds Healthcare Group Inc. (NASDAQ: DSKX) on 10/30/2013, when the stock price was $2.15.
Since then, Ds Healthcare Group Inc. has gained 41.86% as of 01/12/2016's recent price of $3.05.
If you would have followed this Aegis Capital's recommendation on DSKX, you would have gained 41.86% of your investment in 804 days.

Divine Skin, Inc., doing business as DS Laboratories, develops products for skin care and personal care needs. Its skin care products, include Trioxil, an acne cream; Hydroviton, a skin cleanser for oily and acne prone skin; Keramene to suppress hair growth and softens remaining hair strands; Viterol.A, an anti-aging aid to reduce wrinkles and expression lines and improve over-all skin health; and Oligo.DX, a cream to improve the appearance of cellulite from women?s thighs, hips, and buttocks. The company also provides hair care products comprising Spectral.DNC-L to re-grow hair via various pathways; Spectral.RS, which addresses various causes that lead to thinning hair; Revita, a hair growth shampoo; Nia Hydrating Shampoo; and Nia Conditioner. In addition, it offers personal care products, including Nirena, an intimate feminine care cleanser; and beauty care products comprising Revita.EPS, a product based on advanced bio-peptides that are designed to grow and increase the length and girth of eyelash hair. The company markets its products through a network of specialty retailers, spas, salons, and other distributors primarily in North America, Europe, Asia, and South America. Divine Skin, Inc. was founded in 2007 and is headquartered in Miami Beach, Florida.

Aegis Capital
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy